Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
580 | 3 | MULTIPLE MYELOMA//THALIDOMIDE//MYELOMA | 16076 |
3469 | 2 | THALIDOMIDE//THALIDOMIDE ANALOGUES//PHTHALIMIDE | 1602 |
7430 | 1 | THALIDOMIDE//THALIDOMIDE ANALOGUES//THALIDOMIDE ENANTIOMERS | 1394 |
29244 | 1 | N PHTHALOYLGLYCINE//INTERMOLECULAR HALOGEN BOND//1 3 DIOXOISOINDOLINE | 208 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | THALIDOMIDE | authKW | 3630236 | 35% | 33% | 560 |
2 | THALIDOMIDE ANALOGUES | authKW | 192774 | 1% | 70% | 14 |
3 | PHTHALIMIDE | authKW | 142147 | 3% | 17% | 42 |
4 | THALIDOMIDE ENANTIOMERS | authKW | 118030 | 0% | 100% | 6 |
5 | CC 5013 | authKW | 106220 | 1% | 60% | 9 |
6 | RD GRP PHARMACEUT | address | 101167 | 0% | 86% | 6 |
7 | THALIDOMIDE EMBRYOPATHY | authKW | 96387 | 0% | 70% | 7 |
8 | THALIDOMIDE ANALOGS | authKW | 89921 | 0% | 57% | 8 |
9 | TERATOGEN INFORMAT SERV | address | 70813 | 0% | 60% | 6 |
10 | MOL PHARMACOL SECT | address | 70490 | 1% | 16% | 22 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 1808 | 21% | 0% | 342 |
2 | Chemistry, Medicinal | 1581 | 10% | 0% | 159 |
3 | Dermatology | 1568 | 8% | 0% | 127 |
4 | Crystallography | 1547 | 9% | 0% | 142 |
5 | Oncology | 896 | 14% | 0% | 226 |
6 | Toxicology | 694 | 7% | 0% | 111 |
7 | Immunology | 345 | 9% | 0% | 140 |
8 | Chemistry, Organic | 257 | 7% | 0% | 117 |
9 | Hematology | 143 | 4% | 0% | 59 |
10 | Medicine, Research & Experimental | 132 | 5% | 0% | 74 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | RD GRP PHARMACEUT | 101167 | 0% | 86% | 6 |
2 | TERATOGEN INFORMAT SERV | 70813 | 0% | 60% | 6 |
3 | MOL PHARMACOL SECT | 70490 | 1% | 16% | 22 |
4 | ANTITUMOR SUBST | 44260 | 0% | 75% | 3 |
5 | INTENS CARE MED GEN INTERNAL MED | 39343 | 0% | 100% | 2 |
6 | JEROME LIPPER MYELOMA HEMATOL ONCOL | 39343 | 0% | 100% | 2 |
7 | GREATER PHOENIX AREA | 26228 | 0% | 67% | 2 |
8 | HANSENS DIS PROGRAMS | 22405 | 0% | 16% | 7 |
9 | MOL CELLULAR BIOSCI | 22128 | 3% | 2% | 54 |
10 | ANTI CANC DRUG SCREENING IL | 19672 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | TERATOLOGY | 2912 | 1% | 1% | 17 |
2 | ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS | 1306 | 3% | 0% | 41 |
3 | TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS | 1241 | 0% | 1% | 7 |
4 | ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS | 1220 | 1% | 0% | 24 |
5 | REPRODUCTIVE TOXICOLOGY | 892 | 1% | 0% | 11 |
6 | ONCOLOGY-NEW YORK | 820 | 0% | 1% | 8 |
7 | INVESTIGATIONAL NEW DRUGS | 740 | 1% | 0% | 10 |
8 | BIOMEDICINE & PHARMACOTHERAPY | 737 | 1% | 0% | 14 |
9 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 727 | 2% | 0% | 32 |
10 | IMMUNOPHARMACOLOGY | 712 | 0% | 1% | 7 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | THALIDOMIDE | 3630236 | 35% | 33% | 560 | Search THALIDOMIDE | Search THALIDOMIDE |
2 | THALIDOMIDE ANALOGUES | 192774 | 1% | 70% | 14 | Search THALIDOMIDE+ANALOGUES | Search THALIDOMIDE+ANALOGUES |
3 | PHTHALIMIDE | 142147 | 3% | 17% | 42 | Search PHTHALIMIDE | Search PHTHALIMIDE |
4 | THALIDOMIDE ENANTIOMERS | 118030 | 0% | 100% | 6 | Search THALIDOMIDE+ENANTIOMERS | Search THALIDOMIDE+ENANTIOMERS |
5 | CC 5013 | 106220 | 1% | 60% | 9 | Search CC+5013 | Search CC+5013 |
6 | THALIDOMIDE EMBRYOPATHY | 96387 | 0% | 70% | 7 | Search THALIDOMIDE+EMBRYOPATHY | Search THALIDOMIDE+EMBRYOPATHY |
7 | THALIDOMIDE ANALOGS | 89921 | 0% | 57% | 8 | Search THALIDOMIDE+ANALOGS | Search THALIDOMIDE+ANALOGS |
8 | EM12 | 70253 | 0% | 71% | 5 | Search EM12 | Search EM12 |
9 | CC 4047 | 64253 | 0% | 47% | 7 | Search CC+4047 | Search CC+4047 |
10 | CPS49 | 62948 | 0% | 80% | 4 | Search CPS49 | Search CPS49 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 2 |